CliffBio
small molecule

JUNIOR STRENGTH ADVIL

IBUPROFEN

Loss of exclusivity—loss of exclusivity
CompanyHaleon →See this company's full patent-cliff portfolio

Drug detail

Brand nameJUNIOR STRENGTH ADVIL
Active ingredientIBUPROFEN
Strength100MG
Dosage formTABLET, CHEWABLE
RouteORAL
ModalitySmall molecule
FDA approvalDecember 1998
Marketing statusOTC

More from Haleon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.